S&P ASX All Technology

US Dollar vs AUD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

PBYI Puma Biotechnology Inc

4.89

-0.06 (-1.21%)

Last Updated: 05:02:50

Delayed by 15 minutes

Puma Biotechnology and CANbridge terminate NERLYNX license agreement

To read the full story on Seeking Alpha, click here.

Puma Biotechnology (NASDAQ:PBYI)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Puma Biotechnology Charts.

Puma Biotechnology (NASDAQ:PBYI)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Puma Biotechnology Charts.

Puma Biotechnology Inc News

Puma Biotechnology to Host Conference Call to Discuss First Quarter 2024 Financial Results
Friday 19 April 2024 (2 weeks ago) • Business Wire

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Thursday 4 April 2024 (4 weeks ago) • Business Wire

Puma Biotechnology Announces FDA Allowance to Proceed Under IND for Alisertib in HER2-Negative, Hormone Receptor-Positive Metastatic Breast Cancer
Wednesday 20 March 2024 (1 month ago) • Business Wire

Form 8-K - Current report
Friday 1 March 2024 (2 months ago) • Edgar (US Regulatory)

Puma Biotechnology Reports Fourth Quarter and Full Year 2023 Financial Results
Friday 1 March 2024 (2 months ago) • Business Wire

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Wednesday 28 February 2024 (2 months ago) • Business Wire

Puma Biotechnology to Participate in a Panel Discussion at TD Cowen’s 44th Annual Health Care Conference
Friday 23 February 2024 (2 months ago) • Business Wire

Puma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year 2023 Financial Results
Friday 16 February 2024 (3 months ago) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 15 February 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 15 February 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 15 February 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 15 February 2024 (3 months ago) • Edgar (US Regulatory)

More Puma Biotechnology Inc News Articles

Woodside Petroleum

Newcrest Mining

Invesco QQQ Trust Series 1

Australia And New Zealan...

S&P ASX 300 Metals and M...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions